In head and neck cancer [33], breast cancer [34], hepatocellular carcinoma [11] and other cancers, serum RBP4 levels were significantly reduced, and the decrease might be caused by methylation [35]. This evidence concerns the gene RBP4 and hepatocellular carcinoma.